Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Post Hugh 👏Good news coming Mayo Clinic! 🤔👀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Aug 20, 2024 11:41am
67 Views
Post# 36187993

RE:RE:Post Hugh 👏Good news coming Mayo Clinic! 🤔👀

RE:RE:Post Hugh 👏Good news coming Mayo Clinic! 🤔👀
jopatclo wrote: Good comment  
 
@cardinal 4.o, Mayo, reference site partnerships, branding,
 
7
from #vpt, 
 
 
@hassy Interesting to see Hugh's post today. "Working in the US midwest with Strategic Sales Manager Scott Hammerling this past week provided an excellent opportunity to meet with cardiologists and sonographers to discuss how VMS+ can integrate within their clinical workflows. We received positive feedback on the accuracy of RV measurements and the potential to achieve better patient compliance with scheduled studies." Why is this interesting? Mayo's HO happens to be in MN (US Midwest, being a Canadian, I had to look it up to make sure! lol) https://www.linkedin.com/posts/hugh-macnaught-961255_working-in-the-us-midwest-with-strategic-activity-7230719558850859009-GYlL?utm_source=share&utm_medium=member_desktop
 
9
from #vpt, 
 
@cardinal That will be their biggest of the big. What building is that
 
8
from #vpt, 
 
@cardinal Ventripoint is finally there….
 
8
from #vpt, 

jopatclo wrote:

Posts de Hugh





Wow comment positive de 
@Investor765 Well we now know for certain that they were at Mayo clinic. This is positive, even tough it might have been a sale visit ! There is no evidence that any deal is imminent... healthcare takes forever... At least, Hugh is engaging directly Mayo and does not rely on mediocre distributors. I feel more confident knowing he is in the field pitching VPT
and good comment
@cardinal Mayo has over 100 sonographers. They have endless ultrasound and MRI. They need VMS it’s that simple. Ventripoint AI solution and right Ventricle precision is game changing. When Mayo buys, they all buy. GL
 
5 
 
@cardinal six or seven weeks ago was best week ever. Last week was that again.
 
 
6 
 
@cardinal Insiders and family paid .25 in the raise. Look for follow up. Under .25 is a gift

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities